Conatus Pharmaceuticals Appoints Two Additional Independent Board Members

Published February 12, 2014

Conatus Pharmaceuticals Appoints Two Additional Independent Board Members
We are particularly fortunate to have access to these two exceptional resources as we advance our lead drug candidate, emricasan, for multiple potential liver disease applications in parallel." Daniel L. Kisner, M.D.. Dr. Kisner serves … He held a …
Read more on Wall Street Journal

Crohn's Disease SIMPONI PURSUIT Trials from Janssen Inc. Report Positive …
The market for Crohn's Disease treatments continues to grow slowly with the addition of new non-anti-tumor necrosis factor (TNF) biologics, and there may be one more drug to add. Janssen Inc., part of Johnson & Johnson, just announced the results of …
Read more on BioNews Texas

Two decades after sheriff's indictment, corruption cases still dog Rio Grande …
… found guilty of taking bribes in 1994. Marmolejo took bribes for special treatment of Homero Beltran Aguirre, a drug trafficer who was housed in the Hidalgo County Jail. file photo by Delcia Lopez/[email protected] …. In the months following …
Read more on Monitor

Find More Drug Treatment Programs In Texas Information…